Jennifer Lyn Herron - 28 Jun 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jun 2022
Net transactions value
$0
Form type
4
Filing time
30 Jun 2022, 20:27:10 UTC
Previous filing
28 Sep 2021
Next filing
24 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Award $0 +17,237 $0.000000 17,237 28 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock awarded on June 28, 2022, and vests in three equal installments on June 28, 2023, June 28, 2024, and June 28, 2025, subject to the Reporting Person's continued service to the Company on such date.